The T/QRS ratio values in pregnancies complicated by threatened preterm labour treated with intravenous infusions of fenoterol

References

[1] Abdelhak Y, Roque H, Young BK. Terbutaline: effects on the fetal heart at term. J Perinat Med. 2011;40:69–71.10.1515/JPM.2011.095Suche in Google Scholar

[2] Adamcova M, Kokstein Z, Palicka V, Vavrova J, Kostal M, Podholova M, et al. Cardiac troponin T in pregnant women having intravenous tocolytic therapy. Arch Gynecol Obstet. 1999;262:121–6.10.1007/s004040050239Suche in Google Scholar

[3] Anotayanonth S, Subhedar NV, Garner P, Neilson JP, Harigopal S. Betamimetics for inhibiting preterm labour. Cochrane Database Syst Rev. 2004;CD004352.10.1002/14651858.CD004352.pub2Suche in Google Scholar

[4] Barros-Silva J, Pedrosa AC, Matias A. Sonographic measurement of cervical length as a predictor of preterm delivery: a systematic review. J Perinat Med. 2014;42:281–93.10.1515/jpm-2013-0115Suche in Google Scholar

[5] Bastek JA, Sammel MD, Srinivas SK, McShea MA, Foreman MN, Elovitz MA, et al. Clinical prediction rules for preterm birth in patients presenting with preterm labor. Obstet Gynecol. 2012;119:1119–28.10.1097/AOG.0b013e31825503e5Suche in Google Scholar

[6] Berghella V, Owen J, MacPherson C, Yost N, Swain M, Dildy GA, III, et al. Natural history of cervical funneling in women at high risk for spontaneous preterm birth. Obstet Gynecol. 2007;109:863–9.10.1097/01.AOG.0000258276.64005.ceSuche in Google Scholar

[7] Berkman ND, Thorp Jr JM, Lohr KN, Carey TS, Hartmann KE, Gavin NI, et al. Tocolytic treatment for the management of preterm labor: a review of the evidence. Am J Obstet Gynecol. 2003;188:1648–59.10.1067/mob.2003.356Suche in Google Scholar

[8] FIGO. Figo news. Int J Gynaecol Obstet. 1987;25:159–67.10.1016/0020-7292(87)90012-9Suche in Google Scholar

[9] Gemelli M, Luca F, Manganaro R, Leonardi R, Rando F, Agnetti A, et al. Transient electrocardiographic changes suggesting myocardial ischaemia in newborn infants following tocolysis with beta-sympathomimetics. Eur J Pediatr. 1990;149:730–3.10.1007/BF01959533Suche in Google Scholar

[10] Greene KR, Dawes GS, Lilja H, Rosen KG. Changes in the ST waveform of the fetal lamb electrocardiogram with hypoxemia. Am J Obstet Gynecol. 1982;144:950–8.10.1016/0002-9378(82)90190-9Suche in Google Scholar

[11] Hamela-Olkowska A, Szymkiewicz-Dangel J, Wlasienko P, Majewska U, Bokiniec R. [Right ventricular hypertrophic cardiomyopathy in the fetus – may it be caused by chronic oral tocolysis with fenoterol?]. Ginekol Pol. 2012;83:145–8. Polish.Suche in Google Scholar

[12] Iams JD, Goldenberg RL, Meis PJ, Mercer BM, Moawad A, Das A, et al. The length of the cervix and the risk of spontaneous premature delivery. National Institute of Child Health and Human Development Maternal Fetal Medicine Unit Network. N Engl J Med. 1996;334:567–72.10.1056/NEJM199602293340904Suche in Google Scholar PubMed

[13] Junge HD, Kords H, Rodt C. Maternal and fetal ECG alterations during and after infusion of fenoterol. Eur J Obstet Gynecol Reprod Biol. 1978;8:269–76.10.1016/0028-2243(78)90077-1Suche in Google Scholar

[14] Kast A, Hermer M. Beta-adrenoceptor tocolysis and effects on the heart of fetus and neonate. A review. J Perinat Med. 1993;21:97–106.10.1515/jpme.1993.21.2.97Suche in Google Scholar

[15] Mayer M, Minichmayr A, Klement F, Hroncek K, Wertaschnigg D, Arzt W, et al. Tocolysis with the β-2-sympathomimetic hexoprenaline increases occurrence of infantile haemangioma in preterm infants. Arch Dis Child Fetal Neonatal Ed. 2013;98:F108–11.10.1136/archdischild-2011-301030Suche in Google Scholar

[16] Morales WJ, Smith SG, Angel JL, O’Brien WF, Knuppel RA. Efficacy and safety of indomethacin versus ritodrine in the management of preterm labor: a randomized study. Obstet Gynecol. 1989;74:567–72.Suche in Google Scholar

[17] Moutquin JM, Sherman D, Cohen H, Mohide PT, Hochner-Celnikier D, Fejgin M, et al. Double-blind, randomized, controlled trial of atosiban and ritodrine in the treatment of preterm labor: a multicenter effectiveness and safety study. Am J Obstet Gynecol. 2000;182:1191–9.10.1067/mob.2000.104950Suche in Google Scholar

[18] Neri I, Monari F, Valensise H, Vasapollo B, Facchinetti F, Volpe A. Computerized evaluation of fetal heart rate during tocolytic treatment: comparison between atosiban and ritodrine. Am J Perinatol. 2009;26:259–63.10.1055/s-0028-1103153Suche in Google Scholar

[19] Ness A, Visintine J, Ricci E, Berghella V. Does knowledge of cervical length and fetal fibronectin affect management of women with threatened preterm labor? A randomized trial. Am J Obstet Gynecol. 2007;197:426–7.10.1016/j.ajog.2007.07.017Suche in Google Scholar

[20] Nordstrom L, Chua S, Persson B, Aka K, Rulkumaran S. Intrapartum tocolysis has no effect on fetal lactate concentration. Eur J Obstet Gynecol Reprod Biol. 2000;89:165–8.10.1016/S0301-2115(99)00211-0Suche in Google Scholar

[21] Norwitz ER, Robinson JN. A systematic approach to the management of preterm labor. Semin Perinatol. 2001;25:223–35.10.1053/sper.2001.26417Suche in Google Scholar

[22] Papatsonis DN, van Geijn HP, Ader HJ, Lange FM, Bleker OP, Dekker GA. Nifedipine and ritodrine in the management of preterm labor: a randomized multicenter trial. Obstet Gynecol. 1997;90:230–4.10.1016/S0029-7844(97)00182-8Suche in Google Scholar

[23] Papatsonis DN, van Geijn HP, Bleker OP, Ader HJ, Dekker GA. Maternal admission characteristics as risk factors for preterm birth. Eur J Obstet Gynecol Reprod Biol. 2004;112:43–8.10.1016/S0301-2115(03)00272-0Suche in Google Scholar

[24] Parant O, Maillard F, Tsatsaris V, Delattre M, Subtil D, Goffinet F. Management of threatened preterm delivery in France: a national practice survey (the EVAPRIMA study). Br J Obstet Gynaecol. 2008;115:1538–46.10.1111/j.1471-0528.2008.01929.xSuche in Google Scholar

[25] Pryde PG, Besinger RE, Gianopoulos JG, Mittendorf R. Adverse and beneficial effects of tocolytic therapy. Semin Perinatol. 2001;25:316–40.10.1053/sper.2001.27547Suche in Google Scholar

[26] Rauf Z, O’Brien E, Stampalija T, Ilioniu FP, Lavender T, Alfirevic Z. Home labour induction with retrievable prostaglandin pessary and continuous telemetric trans-abdominal fetal ECG monitoring. PLoS One 2011;6:e28129.10.1371/journal.pone.0028129Suche in Google Scholar

[27] Rosen KG, Lindecrantz K. STAN – the Gothenburg model for fetal surveillance during labour by ST analysis of the fetal electrocardiogram. Clin Phys Physiol Meas. 1989;10 (Suppl B):51–6.10.1088/0143-0815/10/4B/008Suche in Google Scholar

[28] Rosen KG, Luzietti R. The fetal electrocardiogram: ST waveform analysis during labour. J Perinat Med. 1994;22:501–12.Suche in Google Scholar

[29] Southern EM. Electrocardiography and phonocardiography of the foetal heart. J Obstet Gynaecol Br Emp. 1954;61:231–7.10.1111/j.1471-0528.1954.tb07472.xSuche in Google Scholar

[30] Valdés E, Salinas H, Toledo V, Lattes K, Cuellar E, Perucca E, et al. Nifedipine versus fenoterol in the management of preterm labor: a randomized, multicenter clinical study. Gynecol Obstet Invest. 2012;74:109–15.10.1159/000338856Suche in Google Scholar

[31] Westgate J, Harris M, Curnow JS, Greene KR. Plymouth randomized trial of cardiotocogram only versus ST waveform plus cardiotocogram for intrapartum monitoring in 2400 cases. Am J Obstet Gynecol. 1993;169:1151–60.10.1016/0002-9378(93)90273-LSuche in Google Scholar